Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ACXP compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ACXP
Acurx Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ACXP
Acurx Pharmaceuticals, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ACXP, solid
LLY, dashed
ACXP
Acurx Pharmaceuticals, Inc.
Change
1.03
▲
+1.11%
· post 1.08
Mkt cap
$4.4M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,419.27
Closed
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 4 '26
ACXP
Acurx Pharmaceuticals, Inc.
vs
LLY
ELI Lilly & Co
1.03
▲
+1.11%
post 1.08
Price
1,417.89
▲
+0.60%
post 1,419.27
$4.4M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
ACXP
1.03
▲
+1.11%
vs
LLY
1,417.89
▲
+0.60%
Closed
Nov 4 '26